Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancerJi Hyun Park, Jae Cheol Lee|Oncotarget|2016Cited by 70
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerChanghwan Sung, Sook Ryun Park, Soo Hyun Lee et al.|Nature Cancer|2023Cited by 46
Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790MKwang Sup So, Jae Cheol Lee|PLoS ONE|2014Cited by 28
Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase InhibitorsYun Jung Choi, Jae Cheol Lee|PLoS ONE|2013Cited by 11